These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31419589)

  • 1. Clinical and neuroimaging characteristics of clinically unclassifiable primary progressive aphasia.
    Utianski RL; Botha H; Martin PR; Schwarz CG; Duffy JR; Clark HM; Machulda MM; Butts AM; Lowe VJ; Jack CR; Senjem ML; Spychalla AJ; Whitwell JL; Josephs KA
    Brain Lang; 2019 Oct; 197():104676. PubMed ID: 31419589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants.
    Josephs KA; Duffy JR; Fossett TR; Strand EA; Claassen DO; Whitwell JL; Peller PJ
    Arch Neurol; 2010 May; 67(5):596-605. PubMed ID: 20457960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progranulin-associated PiB-negative logopenic primary progressive aphasia.
    Josephs KA; Duffy JR; Strand EA; Machulda MM; Vemuri P; Senjem ML; Perkerson RB; Baker MC; Lowe V; Jack CR; Rademakers R; Whitwell JL
    J Neurol; 2014 Mar; 261(3):604-14. PubMed ID: 24449064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia.
    Santos-Santos MA; Rabinovici GD; Iaccarino L; Ayakta N; Tammewar G; Lobach I; Henry ML; Hubbard I; Mandelli ML; Spinelli E; Miller ZA; Pressman PS; O'Neil JP; Ghosh P; Lazaris A; Meyer M; Watson C; Yoon SJ; Rosen HJ; Grinberg L; Seeley WW; Miller BL; Jagust WJ; Gorno-Tempini ML
    JAMA Neurol; 2018 Mar; 75(3):342-352. PubMed ID: 29309493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Qualitative and Quantitative Analyses of Brain 18Fluoro-Deoxy-Glucose Positron Emission Tomography in Primary Progressive Aphasia.
    Nuvoli S; Tanda G; Stazza ML; Madeddu G; Spanu A
    Dement Geriatr Cogn Disord; 2019; 48(5-6):250-260. PubMed ID: 32062656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
    Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
    Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification and clinicoradiologic features of primary progressive aphasia (PPA) and apraxia of speech.
    Botha H; Duffy JR; Whitwell JL; Strand EA; Machulda MM; Schwarz CG; Reid RI; Spychalla AJ; Senjem ML; Jones DT; Lowe V; Jack CR; Josephs KA
    Cortex; 2015 Aug; 69():220-36. PubMed ID: 26103600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated occipital β-amyloid deposition is associated with widespread cognitive impairment in logopenic progressive aphasia.
    Whitwell JL; Lowe VJ; Duffy JR; Strand EA; Machulda MM; Kantarci K; Wille SM; Senjem ML; Murphy MC; Gunter JL; Jack CR; Josephs KA
    J Neurol Neurosurg Psychiatry; 2013 Dec; 84(12):1357-64. PubMed ID: 23946416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    Josephs KA; Martin PR; Botha H; Schwarz CG; Duffy JR; Clark HM; Machulda MM; Graff-Radford J; Weigand SD; Senjem ML; Utianski RL; Drubach DA; Boeve BF; Jones DT; Knopman DS; Petersen RC; Jack CR; Lowe VJ; Whitwell JL
    Ann Neurol; 2018 Mar; 83(3):599-611. PubMed ID: 29451323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF levels of Aβ1-38/Aβ1-40/Aβ1-42 and (11)C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease.
    Ikeda M; Tashiro Y; Takai E; Kurose S; Fugami N; Tsuda K; Arisaka Y; Kodaira S; Fujita Y; Makioka K; Mizuno Y; Shimada H; Harigaya Y; Takatama M; Amari M; Yamazaki T; Yamaguchi H; Higuchi T; Okamoto K; Tsushima Y; Ikeda Y
    Amyloid; 2014 Dec; 21(4):238-45. PubMed ID: 25139672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognition and anatomy in three variants of primary progressive aphasia.
    Gorno-Tempini ML; Dronkers NF; Rankin KP; Ogar JM; Phengrasamy L; Rosen HJ; Johnson JK; Weiner MW; Miller BL
    Ann Neurol; 2004 Mar; 55(3):335-46. PubMed ID: 14991811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer's Disease.
    Louwersheimer E; Keulen MA; Steenwijk MD; Wattjes MP; Jiskoot LC; Vrenken H; Teunissen CE; van Berckel BN; van der Flier WM; Scheltens P; van Swieten JC; Pijnenburg YA
    J Alzheimers Dis; 2016; 51(2):581-90. PubMed ID: 26890751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia.
    Mandelli ML; Vilaplana E; Brown JA; Hubbard HI; Binney RJ; Attygalle S; Santos-Santos MA; Miller ZA; Pakvasa M; Henry ML; Rosen HJ; Henry RG; Rabinovici GD; Miller BL; Seeley WW; Gorno-Tempini ML
    Brain; 2016 Oct; 139(Pt 10):2778-2791. PubMed ID: 27497488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular neuroimaging in primary progressive aphasia with predominant agraphia.
    Utianski RL; Duffy JR; Savica R; Whitwell JL; Machulda MM; Josephs KA
    Neurocase; 2018 Apr; 24(2):121-123. PubMed ID: 29569990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning in the clinical and language characterisation of primary progressive aphasia variants.
    Matias-Guiu JA; Díaz-Álvarez J; Cuetos F; Cabrera-Martín MN; Segovia-Ríos I; Pytel V; Moreno-Ramos T; Carreras JL; Matías-Guiu J; Ayala JL
    Cortex; 2019 Oct; 119():312-323. PubMed ID: 31181419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type.
    Madhavan A; Whitwell JL; Weigand SD; Duffy JR; Strand EA; Machulda MM; Tosakulwong N; Senjem ML; Gunter JL; Lowe VJ; Petersen RC; Jack CR; Josephs KA
    PLoS One; 2013; 8(4):e62471. PubMed ID: 23626825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
    Cerami C; Dodich A; Greco L; Iannaccone S; Magnani G; Marcone A; Pelagallo E; Santangelo R; Cappa SF; Perani D
    J Alzheimers Dis; 2017; 55(1):183-197. PubMed ID: 27662315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and neuroimaging biomarkers of amyloid-negative logopenic primary progressive aphasia.
    Whitwell JL; Duffy JR; Strand EA; Machulda MM; Senjem ML; Schwarz CG; Reid R; Baker MC; Perkerson RB; Lowe VJ; Rademakers R; Jack CR; Josephs KA
    Brain Lang; 2015 Mar; 142():45-53. PubMed ID: 25658633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, Imaging, and Pathologic Characteristics of Patients With Right vs Left Hemisphere-Predominant Logopenic Progressive Aphasia.
    Buciuc M; Duffy JR; Machulda MM; Graff-Radford J; Pham NTT; Martin PR; Senjem ML; Jack CR; Ertekin-Taner N; Dickson DW; Lowe VJ; Whitwell JL; Josephs KA
    Neurology; 2021 Aug; 97(5):e523-e534. PubMed ID: 34088877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.